FDA Inspection
Department of Defense - Air ForceDepartment of Defense - Air Force – FDA Inspection, Apr 14, 2025
Record Details
This FDA Inspection record concerns Department of Defense - Air Force, with an inspection on April 14, 2025, issued by the Cincinnati District Office, covering biologics.
View Company Profile
ID · 5f0af7a7-0280-4470-888b-1a133e30ec64
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1266836
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 630.40(c)Notification w/in 8 weeks
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Air Force
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 30, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 26, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 19, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 7, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 21, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Air Force
- FDA Inspection 1166032 - 2022-03-30
- FDA Inspection 1103404 - 2019-09-26
- FDA Inspection 1026018 - 2017-09-19
- FDA Inspection 937774 - 2015-08-07
- FDA Inspection 812221 - 2012-12-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.